Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.0K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.4K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep inverse reinforcement learning for structural evolution of small molecules.

Briefings in bioinformatics·2020
Same author

Markov Task Network: A Framework for Service Composition under Uncertainty in Cyber-Physical Systems.

Sensors (Basel, Switzerland)·2016
Same author

[Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery·2010
Same author

Hyperactive putamen in patients with paroxysmal kinesigenic choreoathetosis: a resting-state functional magnetic resonance imaging study.

Movement disorders : official journal of the Movement Disorder Society·2010
Same author

Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.

European journal of pharmacology·2010
Same author

The effect of Zr content on the microstructure, mechanical properties and cell attachment of Ti-35Nb-xZr alloys.

Biomedical materials (Bristol, England)·2010

Related Experiment Video

Updated: Dec 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K

Multi-view self-attention for interpretable drug-target interaction prediction.

Brighter Agyemang1, Wei-Ping Wu1, Michael Yelpengne Kpiebaareh1

  • 1School of Computer Science and Engineering, University of Electronic Science and Technology of China, Chengdu, PR China; SipingSoft Co. Ltd., Tianfu Software Park, Chengdu, PR China.

Journal of Biomedical Informatics
|August 30, 2020
PubMed
Summary

This study introduces a novel self-attention method for machine learning in drug discovery, improving the prediction of drug-target interactions and offering interpretable results for pharmacology.

Keywords:
Drug discoveryDrug–target interactionsMachine learningRepresentation learningSelf-attention

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K

Related Experiment Videos

Last Updated: Dec 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K

Area of Science:

  • Computational chemistry
  • Machine learning in drug discovery
  • Pharmacology

Background:

  • Drug discovery is a critical early stage in pharmaceutical development.
  • Machine learning (ML) methods are increasingly used for rational drug discovery, particularly for modeling drug-target interactions.
  • Effective numerical representation of molecules and model interpretability are key challenges in ML-based drug discovery.

Purpose of the Study:

  • To propose a novel self-attention-based multi-view representation learning approach for modeling drug-target interactions.
  • To enhance the prediction performance and interpretability of ML models in drug discovery.
  • To provide biologically plausible explanations for predicted drug-target interactions.

Main Methods:

  • Developed a self-attention-based multi-view representation learning framework.
  • Applied the method to model drug-target interactions.
  • Utilized three benchmark kinase datasets for evaluation.
  • Compared the proposed approach against established baseline models.

Main Results:

  • The proposed method achieved competitive prediction performance on benchmark datasets.
  • The approach demonstrated the ability to provide biologically plausible interpretations of drug-target interactions.
  • Experimental results validate the effectiveness of the self-attention mechanism in this context.

Conclusions:

  • The self-attention-based multi-view representation learning approach is effective for modeling drug-target interactions.
  • This method offers a promising direction for rational drug discovery by improving both prediction accuracy and interpretability.
  • The findings have potential pharmacological applications by providing insights into drug-target relationships.